{
  "@context": "https://frontierpicks.com/schemas/dossier.v1.json",
  "ticker": "SNPS",
  "name": "Synopsys, Inc.",
  "url": "https://frontierpicks.com/dossiers/SNPS/",
  "json_url": "https://frontierpicks.com/dossiers/SNPS.json",
  "status": "WATCHLIST",
  "current_conviction": "MEDIUM",
  "archetype": {
    "code": "a2",
    "n": 2
  },
  "current_thesis": "Synopsys has a second growth engine in AI custom-chip design: its fiscal 2027 guide of $11.1–11.2 billion in revenue, plus deals with Amazon and OpenAI, beat consensus. The early-December fourth-quarter report shows whether results keep pace.",
  "invalidation_trigger": "A daily close below $460, which would give back a large part of the rally after the 2026-09-30 investor day. A cut to the fiscal 2027 revenue guide of $11.1–11.2 billion at the December report would also end the case.",
  "catalyst_date": null,
  "pick": {
    "id": "P-2026-10-12-SNPS",
    "conviction": "MEDIUM",
    "status": "open",
    "opened": "2026-10-12",
    "open_close": 502.51,
    "kill_level": 460,
    "kill_basis": "daily",
    "horizon_end": "2027-01-12",
    "last_date": "2026-10-12",
    "last_close": 502.51,
    "return_pct": 0,
    "spy_return_pct": 0,
    "excess_pp": 0,
    "kill_distance_pct": 9.241304347826084,
    "closed": null,
    "close_reason": null,
    "outcome": null,
    "scoreboard": "https://frontierpicks.com/track-record/"
  },
  "themes": [
    "semi-foundry-equipment"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Synopsys' fiscal year ends in late October, so its fourth-quarter and full-year results usually come out in December.",
    "Synopsys reports large gaps between GAAP and non-GAAP earnings, mostly from amortization of the 2025 Ansys acquisition and from stock compensation.",
    "Year-over-year revenue comparisons through mid-2026 are inflated by Ansys, which Synopsys bought in July 2025."
  ],
  "body_markdown": "## Current Thesis\nSynopsys has a second growth engine in AI custom-chip design. Its fiscal 2027 outlook of $11.1–11.2 billion in revenue and $19.04–19.12 in adjusted earnings per share (EPS), issued at the 2026-09-30 investor day, sits well above the consensus of $10.73 billion and $17.32 that Benzinga reported. The fourth-quarter fiscal 2026 report, estimated for around 2026-12-09, is the first test of whether results keep pace with that guide.\n\nThe case rests on three new facts from the same day. Amazon signed a multi-year deal worth more than $1 billion to license Synopsys chip-design IP (intellectual property) and software for its Nitro, Graviton and Trainium processors. OpenAI agreed to build GPT-Synopsys, a chip-design model, with shared revenue. Synopsys also started a $1 billion accelerated share repurchase with JPMorgan Chase. The shares have already priced in much of this. They closed at $509.99 on 2026-10-09, with a 14-day relative strength index (RSI) of 86.4, so the next three months depend on delivery more than on new announcements.\n\nThe narrative is accelerating: the investor-day guide, the Amazon and OpenAI contracts and a run of target increases on 2026-10-01 all brought new attention within the past two weeks.\n\n## Bull Case\n- **Guidance cleared consensus by a wide margin.** On 2026-09-30 Synopsys guided fiscal 2027 revenue to $11.1–11.2 billion against a $10.73 billion estimate, and adjusted EPS to $19.04–19.12 against $17.32, according to Benzinga. The company described this as about 15% revenue growth.\n- **Amazon contract adds royalty income.** The Amazon deal, worth more than $1 billion and announced 2026-09-30, uses a license-plus-royalty model. Part of the revenue from the deal will rise with Amazon's chip production volumes.\n- **Margin targets were set out to 2030.** At the investor day the company set a target of about 50% non-GAAP operating margin by 2030, against 44.0% at the fiscal 2027 midpoint. It also targeted mid-20s percent annual growth in EPS and free cash flow from fiscal 2026 to 2030.\n- **Cash is being returned to shareholders.** Synopsys expects about $2.6 billion of free cash flow in fiscal 2026 (2026-08-26 release) and about $3.1 billion in fiscal 2027. It started a $1 billion accelerated repurchase in early October and aims to return up to 50% of free cash flow through buybacks.\n- **Analysts raised targets after the event.** On 2026-10-01 Rosenblatt raised its target to $620, KeyBanc to $605 and Wells Fargo to $540, with all three keeping positive ratings.\n\n## Bear Case\n- **The shares are stretched after the jump.** The shares rose 10.8% on 2026-10-01 after the guide and are up 19.7% over three months to 2026-10-09. An RSI of 86.4 is far above the 70 level usually read as overbought, and Benzinga named Synopsys among overbought tech stocks on 2026-10-07.\n- **The adjusted figures hide large costs.** Fiscal 2027 GAAP EPS guidance is $8.16–8.61, well below the $19.04–19.12 adjusted range. Much of the gap comes from acquisition amortization and stock compensation following the Ansys deal.\n- **Reported growth is flattered by the Ansys deal.** Third-quarter fiscal 2026 revenue was $2.477 billion against $1.740 billion a year earlier (2026-08-26 release), but most of that jump comes from adding Ansys, which closed in July 2025.\n- **Exposure to China and export rules.** Nikkei Asia reported on 2026-10-08 that Synopsys wants to work with Chinese AI labs. In May 2025 the US Commerce Department required licenses for chip-design software sales to China, then lifted the rule in July 2025, so this sales channel depends on policy.\n- **Higher bond yields weigh on high-multiple stocks.** The 10-year Treasury yield was near 5.25% on 2026-10-01, a level that weighs on richly valued software stocks.\n\n## Setup & Price Structure\nOn 2026-10-09 the shares closed at $509.99, 4.6% below their 52-week high of $534.56. The move came almost entirely in one gap, on 2026-10-01, when the shares rose 10.8% on a day the S&P 500 fell. Two of the three analyst targets raised that day sit above the 2026-10-09 close: Rosenblatt at $620 and KeyBanc at $605. Wells Fargo's target of $540 is only modestly higher.\n\nThe sell-side view is not unanimous. Earlier in the fall, Piper Sandler kept a Neutral rating with a $450 target and Morgan Stanley kept Equal Weight with $525. A daily close below $460 would mean the shares had given back a large part of the post-investor-day rally. The guide would then no longer be supporting the price.\n\n## Catalyst Calendar (next 30 days)\n- **2026-10-31:** fiscal 2026 ends. The fourth-quarter guide is $2.53–2.58 billion in revenue and $4.10–4.16 in adjusted EPS (2026-08-26 release).\n- **~2026-10-30, est.:** Synopsys usually announces its fourth-quarter report date around this point. It did so on 2025-10-30 last year.\n- **~2026-12-09, est. (outside 30 days):** fourth-quarter and full-year fiscal 2026 results. This is the first report since the fiscal 2027 guide and the event the three-month case turns on.\n\n## What Would Change Our Mind\nThe case breaks if Synopsys cuts or narrows the fiscal 2027 revenue range of $11.1–11.2 billion at the December report. It also breaks if fourth-quarter revenue lands below the $2.53 billion low end of the guide. Either would show the investor-day outlook ran ahead of the business.\n\nTwo other events would weaken the case. One is a delay or reduced scope in the Amazon royalty deal. The other is a new US license requirement on chip-design software sales to China. On price, a daily close below $460 would show the market no longer supports the guide.\n\n## Correlation Notes\nSynopsys trades with Cadence Design Systems, its main rival in chip-design software. It also trades with the AI chip complex that drives chip-design budgets, including TSMC, the custom-silicon programs at Amazon and the Nasdaq 100. The Nasdaq 100 hit a record in the week to 2026-10-02.\n\nThe semiconductor foundry and equipment group has drawn heavy attention through September and October. Synopsys' gain is tied to its own guidance, but a broad pullback in AI semiconductor stocks or a further rise in the 10-year yield above 5.25% would likely pull the shares down with the group. The $1 billion repurchase underway provides some buying of the company's own shares that peers without buybacks lack.",
  "first_seen": "2026-10-11",
  "last_analyzed": "2026-10-11T11:03:29+00:00",
  "last_synthesized": "2026-10-11",
  "last_update_source": "theme_discovery",
  "license": "Content © FrontierPicks. Cite the canonical URL."
}